Veraxa Biotech Holding AG Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Oliver Rolf Baumann, a Director of Veraxa Biotech Holding AG, purchased 50,000 shares of common stock on August 27, 2026 for $1.50 per share.
NASDAQ
Christoph Rudiger Antz, Chief Executive Officer and a Director of Veraxa Biotech Holding AG, purchased 5,000 shares of common stock on August 27, 2026 for $1.53 per share.
NASDAQ
VERAXA Biotech and Secarna Pharmaceuticals announced a strategic research collaboration to develop next-generation antibody oligonucleotide conjugates for autoimmune and inflammatory diseases.